Razelle Kurzrock, MD
@Dr_R_Kurzrock
Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine
Babies 🧵 This wholesome thread is the happiness refresh button you didn’t know you needed 1. When you realize that even your legs are under your own control
Committee consensus= everyone knows who is the power leader, waits to hear their opinion, and then agrees
The Castleman’s National expert panel reviews complex patients. Discussions are in depth and all effort is on helping individual patients
Precision Pedalers Audaxity bike ride bake sale. Raising money to fund cancer research. Nice work from the team
We would like to inform you that your post has been published on OncoDaily. Thank you for sharing. oncodaily.com/blog/supriya-p…
I went into academia to search for truth. I left learning how to write safe grants, avoid controversy, and serve bureaucrats.
Cub’s great escape instantly canceled by Mum
Best boat captain!
Nice memory from September 28, 2024 @WIN_Consortium
What are "omics"? A good schematic cell.com/neuron/fulltex… could add epigenomics, immunomics, microbiomics, glycomics, exposomics, etc
Wonderful to see @jillfeldman4 a member of our @PallOncCoP patient pillar in this important paper!
Activating mutations in EGFR gene has revolutionized management of #LungCancer, enabling development of TKIs. New review on strategies to optimize treatment: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @Alfdoc2 @Maxime_Borgeaud @Timothee_MD @JairBar4 @kaushalpar @jillfeldman4 @LeXiuning @OncoAlert
Beautiful review from @KimmieNgMD @DanaFarber! Such an important topic with implications for early cancer onset across the spectrum of cancers. @mgfakih @gagan_brar24 @DaniCastilloMD @DanengLi @mzugman
From @JAMA_current: Early-onset gastrointestinal cancers are among the largest subset of early-onset cancers globally. This JAMA Review summarizes current evidence on early-onset gastrointestinal cancers. ja.ma/3GSXvOo @KimmieNgMD @DanaFarber
At NOSCM, @JuliaRotow presents provocative data supporting continuation of EGFR TKIs after progressive disease, so-called treatment beyond progression (TBP). I am increasingly a believer. Invariably there are residual sensitive clones which need to be controlled
The twin sins of institutional dysfunction Responsibility without authority Authority without responsibility
Looking forward to Dr. Kaelin’s keynote in Philly @WIN_Consortium Symposium @AdvancingPM. He joins a distinguished group of global leaders in genomics, oncology, and translational science—driving the future of individualized care. Register web.cvent.com/event/e4273403… @Dr_R_Kurzrock
Password Bot Admits It Sometimes Says 'Incorrect Password' On Your First Try Just To Mess With You | Babylon Bee: this is really funny. Worth reading babylonbee.com/news/password-…
Imagine you're covering neurosurgery call. You're out trying to enjoy a nice family dinner, or maybe it's the middle of the night. Suddenly, you're called away for an acute traumatic subdural hematoma. You get there, the patient is herniating. You rush to the OR and…
The @WIN_Consortium in Personalized Cancer Medicine is happy to collaborate and partner with colleagues in academia, foundations, government, pharma, advocacy groups, professional societies and other key stakeholders. #AACR25 @ASCO @AACR @AACRPres @Dr_R_Kurzrock
Oncologists Arriving at ASCO Returning from ASCO #ASCO25
Not everything in oncology can be taught. Some things you just feel and fight for.
From the diary of an oncologist -